-
Market Watch - Thu Oct 22, 4:40 am ET
Swiss pharmaceutical giant Novartis' third-quarter profit is virtually unchanged, as growing sales of cancer and hypertension medications offset charges and declining vaccine sales.
-
Christian News Wire - Thu Oct 22, 9:56 am ET
WASHINGTON, Oct. 22 / Standard Newswire / -- The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency's long-standing programs in disease surveillance, training, and outbreak response, particularly those addressing avian and pandemic influenza.
-
The Morning Call - Thu Oct 22, 7:06 am ET
Drugmakers show more interest; supplies likely to grow as threat of pandemics increases Vaccine shortages, commonplace a few years ago, soon may be a thing of the past.
-
PitchEngine - Thu Oct 22, 8:55 am ET
ANNAPOLIS, MD. iJET Intelligent Risk Systems, a leading provider of global intelligence and business resiliency services, today issued an advisory recommending that companies examine and activate pandemic preparedness plans in advance of what the intelligence firm forecasts will be a severe 2009-2010 flu season augmented by the ongoing H1N1 2009 virus pandemic. iJETs predictive intelligence...
-
PR Newswire via Yahoo! Finance - Thu Oct 22, 9:30 am ET
Sinovac Biotech Ltd. , a leading developer and provider of vaccines in China, today announced that it has received a Certificate of Approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza vaccine, in Mexico.
-
Tri-Town News - Wed Oct 21, 9:00 pm ET
The reappointment of the Howell K-8 School District Board of Education's longtime auditor was contested by a board member at a recent meeting. Board member Timothy O'Brien opposed the selection of Robert Hulsart as auditor for the 2010-11 school year at an Oct. 7 board meeting.
-
IRIN - Wed Oct 21, 11:30 am ET
DAKAR, 21 October 2009 (IRIN) - Yellow fever is a ticking time bomb, while measles has been eliminated three years ahead of schedule in parts of Africa and the Eastern Mediterranean. These are among the highlights of the most recent World Health Organization (WHO) report, State of the World's Vaccines and Immunization:
-
The Capital Times - Sun Oct 18, 6:09 am ET
Dear Editor: An animal biosafety laboratory for the purpose of studying bird flu and other highly infectious diseases will be built by the University of Wisconsin-Madison two blocks east of Camp Randall Stadium.
-
GenomeWeb News - Sun Oct 11, 10:15 pm ET
NIH announced that a vaccine for H5N1 avian flu designed by scientists at the National Institute of Allergy and Infectious Diseases has entered clinical trials . The DNA-based vaccine is the first to start human trials, according to NIH. If all goes well with this vaccine, it could help pave the way for development of other DNA-based, rather than virus-based, vaccines.
-
redOrbit - Tue Oct 20, 2:08 pm ET
SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus.
-
The News Herald - Tue Oct 20, 11:40 pm ET
PANAMA CITY — A draft document that would guide state hospitals in the event of a “pandemic influenza or other health emergency” has received input from officials with the Bay County Health Department. The draft was released earlier than...
-
Center for Infectious Disease Research and Policy - Tue Oct 20, 6:49 pm ET
Oct 20, 2009 (CIDRAP News) – The German Ministry of Food, Agriculture & Consumer Protection (BMELV) today announced that it has agreed to host the influenza gene sequence database of the Global Initiative on Sharing All Influenza Data (GISAID), putting its future on a more solid footing as the world enters the second wave of the H1N1 flu pandemic.
-
The University of Alabama at Birmingham - Tue Oct 20, 3:02 pm ET
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.
-
PR Newswire via Yahoo! Finance - Mon Oct 19, 1:26 pm ET
There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change, e.g., before the disease has come and gone.
-
Chicago Tribune - Sun Oct 18, 8:42 pm ET
Cell-based method cuts production time; increased demand boosts sales potential Vaccine shortages, commonplace a few years ago, soon may be a thing of the past now that more companies are producing and improving vaccines as governments worldwide prepare for potential pandemics.
